Lithium is poised to become a red-hot commodity in the basic materials sector, driven by a couple of key macro tailwinds. First and foremost, the new data center buildout across the United States will require a decent amount of lithium to be used in the supercomputers that will train tomorrow's leading artificial intelligence models.

Ideal Power Inc (NASDAQ:IPWR) said on Thursday its first design win customer is close to completing prototype testing for a B-TRAN-enabled solid-state circuit breaker (SSCB) ahead of a planned rollout later this year. “Our first design win customer is nearing completion of their B-TRAN-enabled solid-state circuit breaker (SSCB) prototype testing,” CEO Dan Brdar said in a statement.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has enrolled and dosed the first participant in its Phase 2a clinical trial evaluating intranasal foralumab in patients with Multiple System Atrophy (MSA). The trial is being conducted at Brigham and Women's Hospital in Boston, Massachusetts.

I rate VanEck Alternative Asset Manager ETF a Buy, targeting capital appreciation from the surge in alternative investments entering 401Ks after a recent executive order. The GPZ ETF offers exposure to the top 20 public alternative asset managers, benefiting from a $12.5 trillion retirement market and outpacing the financial sector since launch. The ETF provides diversification across private equity, credit, infrastructure, and real estate, with a low expense ratio and minimal direct competition among ETFs.

Bitcoin enjoyed a long summer in the spotlight, as prices notched new records and regulatory policy proved favorable. Not to be outdone, the Ethereum network made a number of headlines in recent weeks.

Central banks' willingness to buy more precious metals should help buoy prices for both gold and silver. Around the globe, central banks continue to quench their thirst for both, providing investment opportunities in ETFs with exposure to both metals.

CEG beats on Q2 earnings and revenues, secures Meta deal, and advances nuclear and renewable growth plans.

The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.

Investors need to pay close attention to CADE stock based on the movements in the options market lately.

ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease.

Xilio Therapeutics, Inc. (XLO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.24 per share a year ago.

Heritage Insurance is pivoting to growth after years of consolidation, boasting improved underwriting and a more diversified geographic footprint beyond Florida. The company relies heavily on reinsurance, which acts as off-balance-sheet leverage, masking the true risk profile and increasing exposure to annual reinsurance market changes. Heritage's growth plans coincide with a softening insurance market, raising concerns about profitability as pricing power declines and catastrophe risks remain elevated.

Shares of Tesla Inc. (NASDAQ: TSLA) are trading for 5.3% more than a week ago as the EV ramps up for its robotaxi launch.

CHANTILLY, Va.--(BUSINESS WIRE)--Red River has been named the NetApp North America Civilian Partner of the Year.

CHERRY HILL, N.J.--(BUSINESS WIRE)--For the sixth consecutive year, TD Auto Finance, a division of TD Bank, N.A., received the highest ranking in Dealer Satisfaction among National Non-Captive Prime Credit Lenders, according to the J.D. Power 2025 U.S. Dealer Financing Satisfaction Study. “At TD Bank, we're focused on delivering exceptional experiences that make a difference in the lives of our customers,” said Andrew Stuart, Head of U.S. Consumer Products, Auto Finance & Wealth, TD Bank. “.

Key Points in This Article: Bullish (BLSH) is a Peter Thiel-backed crypto exchange targeting institutional investors with advanced trading tools.

Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.

Volato Group Inc said on Thursday it is on track to close its planned all-stock merger with M2i Global (OTC:MTWO) in the fourth quarter of 2025, as the private aviation company reported its second consecutive quarterly profit and sharply reduced liabilities. A joint integration team is finalizing readiness plans across finance, IT, cybersecurity, procurement and compliance, with early cost synergies expected to be implemented immediately after the deal closes.

Xunlei Limited (NASDAQ:XNET ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Jinbo Li - Chairman & CEO Luhan Tang - Investor Relations Manager Zhou Naijiang - Chief Financial Officer Conference Call Participants Operator Welcome, ladies and gentlemen, and thank you for your patience. You've joined Xunlei's Second Quarter 2025 Earnings Conference Call.

CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.